Skip to content

In the BioHarmony Drug Report Database

Daunorubicin

Cerubidine, Daunorubicin, Vyxeos (daunorubicin) is a small molecule pharmaceutical. Daunorubicin was first approved as Cerubidine on 1982-01-01. It is used to treat myeloid leukemia acute and precursor cell lymphoblastic leukemia-lymphoma in the USA. It has been approved in Europe to treat myeloid leukemia acute.
Trade Name Vyxeos liposomal, known as Vyxeos
Common Name Daunorubicin
Indication myeloid leukemia acute, precursor cell lymphoblastic leukemia-lymphoma
Drug Class Antineoplastic antibiotics (daunorubicin type)
Daunorubicin
Get full access now